{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:17:52Z","timestamp":1783462672101,"version":"3.55.0"},"reference-count":276,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bcp.2020.114043","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:13:56Z","timestamp":1590009236000},"page":"114043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Venom-derived modulators of epilepsy-related ion channels"],"prefix":"10.1016","volume":"181","author":[{"given":"Chun Yuen","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Absalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn F.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114043_b0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","article-title":"Epilepsy: new advances","volume":"385","author":"Mosh\u00e9","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114043_b0020","doi-asserted-by":"crossref","unstructured":"Billakota S, Devinsky O, Kim KW, Why we urgently need improved epilepsy therapies for adult patients, Neuropharmacology (2019) 107855.","DOI":"10.1016\/j.neuropharm.2019.107855"},{"key":"10.1016\/j.bcp.2020.114043_b0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(06)70448-3","article-title":"Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study","volume":"5","author":"Mohanraj","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2016.11.030","article-title":"Epilepsy-associated genes","volume":"44","author":"Wang","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.bcp.2020.114043_b0035","series-title":"Ion Channels of Excitable Membranes","author":"Hille","year":"2001"},{"key":"10.1016\/j.bcp.2020.114043_b0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12264-017-0134-1","article-title":"Ion Channel genes and epilepsy: functional alteration, pathogenic potential, and mechanism of epilepsy","volume":"33","author":"Wei","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bcp.2020.114043_b0045","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bcp.2020.114043_b0050","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/toxins2122851","article-title":"Spider-venom peptides as therapeutics","volume":"2","author":"Saez","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114043_b0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmb.2014.07.027","article-title":"From foe to friend: using animal toxins to investigate ion channel function","volume":"427","author":"Kalia","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-ento-120811-153650","article-title":"Spider-venom peptides: structure, pharmacology, and potential for control of insect pests","volume":"58","author":"King","year":"2013","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.bcp.2020.114043_b0065","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ps.5452","article-title":"Tying pest insects in knots: the deployment of spider-venom-derived knottins as bioinsecticides","volume":"75","author":"King","year":"2019","journal-title":"Pest Manage. Sci."},{"key":"10.1016\/j.bcp.2020.114043_b0070","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd1197","article-title":"Therapeutic potential of venom peptides","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2020.114043_b0075","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.bmc.2017.09.029","article-title":"Peptide therapeutics from venom: current status and potential","volume":"26","author":"Pennington","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b0080","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40263-013-0107-5","article-title":"Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics","volume":"27","author":"Sanford","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2020.114043_b0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.toxicon.2013.03.017","article-title":"New insights on arthropod toxins that potentiate erectile function","volume":"69","author":"Nunes","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0090","doi-asserted-by":"crossref","first-page":"17534","DOI":"10.1073\/pnas.1306285110","article-title":"Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models","volume":"110","author":"Yang","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b0095","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1073\/pnas.1614728114","article-title":"Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a","volume":"114","author":"Chassagnon","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fphar.2018.00145","article-title":"Animal toxins as therapeutic tools to treat neurodegenerative diseases","volume":"9","author":"de Souza","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0105","doi-asserted-by":"crossref","first-page":"E8077","DOI":"10.1073\/pnas.1804764115","article-title":"Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death","volume":"115","author":"Richards","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcp.2018.08.038","article-title":"Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target","volume":"158","author":"Ma","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acsptsci.9b00079","article-title":"Venom peptides with dual modulatory activity on the voltage-gated sodium channel NaV1.1 provide novel leads for development of antiepileptic drugs","volume":"3","author":"Chow","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bcp.2020.114043_b0120","unstructured":"World Health Organisation. Epilepsy: a public health imperatiEve. Available online at https:\/\/www.who.int\/mental_health\/neurology\/epilepsy\/report_2019\/en\/, 2019."},{"issue":"Suppl 11","key":"10.1016\/j.bcp.2020.114043_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1167.2005.00403.x","article-title":"Mortality of epilepsy in developed countries: a review","volume":"46","author":"Forsgren","year":"2005","journal-title":"Epilepsia"},{"issue":"Suppl 11","key":"10.1016\/j.bcp.2020.114043_b0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2005.00406.x","article-title":"Cause-specific mortality in epilepsy","volume":"46","author":"Lhatoo","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174659","article-title":"Cause of death in patients with poststroke epilepsy: results from a nationwide cohort study","volume":"12","author":"Hansen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2020.114043_b0140","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1528-1157.2003.56102.x","article-title":"The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects","volume":"44","author":"Luyken","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \u201fcommon\u201d neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114043_b0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.58.4.537","article-title":"Long-term mortality after a first episode of status epilepticus","volume":"58","author":"Logroscino","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114043_b0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s004150050004","article-title":"Mortality in epilepsy","volume":"247","author":"Tomson","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nrn3708","article-title":"Electrical synapses and their functional interactions with chemical synapses","volume":"15","author":"Pereda","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mrdd.1410010309","article-title":"Role of glutamate and GABA in the pathophysiology of epilepsy","volume":"1","author":"Holmes","year":"1995","journal-title":"Ment. Retard Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0170","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.2058","article-title":"Enhanced tonic GABAA inhibition in typical absence epilepsy","volume":"15","author":"Cope","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2020.114043_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157015908783769653","article-title":"GABAA receptors in normal development and seizures: friends or foes?","volume":"6","author":"Galanopoulou","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of GABA during development: the nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroscience.2010.11.045","article-title":"Developmental maturation of excitation and inhibition balance in principal neurons across four layers of somatosensory cortex","volume":"174","author":"Zhang","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2020.114043_b0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114043_b0195","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/brain\/awp187","article-title":"Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy","volume":"132","author":"Berg","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1474-4422(08)70039-5","article-title":"Navigating the channels and beyond: unravelling the genetics of the epilepsies","volume":"7","author":"Helbig","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0205","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/brain\/awp028","article-title":"Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures","volume":"132","author":"Blumenfeld","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1095-201","article-title":"A missense mutation in the neuronal nicotinic acetylcholine receptor \u03b14 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy","volume":"11","author":"Steinlein","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng.3153","article-title":"Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy","volume":"47","author":"Simons","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0220","first-page":"881","article-title":"Brain somatic mutations in epileptic disorders","volume":"41","author":"Koh","year":"2018","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bcp.2020.114043_b0225","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.aan8690","article-title":"Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis","volume":"359","author":"Bae","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pneurobio.2008.09.016","article-title":"Mechanisms of human inherited epilepsies","volume":"87","author":"Reid","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bcp.2020.114043_b0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13041-015-0099-9","article-title":"Ontogeny of biochemical, morphological and functional parameters of synaptogenesis in primary cultures of rat hippocampal and cortical neurons","volume":"8","author":"Harrill","year":"2015","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bcp.2020.114043_b0240","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nn.3944","article-title":"Reprogramming patient-derived cells to study the epilepsies","volume":"18","author":"Parent","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13311-014-0267-0","article-title":"Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models","volume":"11","author":"Guerrini","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2020.114043_b0250","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2147\/NDT.S50371","article-title":"Animal models of epilepsy: use and limitations","volume":"10","author":"Kandratavicius","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bcp.2020.114043_b0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WCO.0b013e32835ee6ff","article-title":"Genetics of the epilepsies: where are we and where are we going?","volume":"26","author":"Helbig","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0260","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/humu.22782","article-title":"The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype","volume":"36","author":"Meng","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2020.114043_b0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cge.12999","article-title":"Confirming the recessive inheritance of SCN1B mutations in developmental epileptic encephalopathy","volume":"92","author":"Ramadan","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/brain\/aww272","article-title":"De novo GABRG2 mutations associated with epileptic encephalopathies","volume":"140","author":"Shen","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b0275","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1528-1167.2008.01619.x","article-title":"Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures","volume":"49","author":"Misra","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0280","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0285","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1073858418763752","article-title":"Potassium channel gain of function in epilepsy: an unresolved paradox","volume":"24","author":"Niday","year":"2018","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bcp.2020.114043_b0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40263-013-0063-0","article-title":"The long-term safety of antiepileptic drugs","volume":"27","author":"Gaitatzis","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2020.114043_b0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2005.00506.x","article-title":"Adverse effects of antiepileptic drugs","volume":"181","author":"Perucca","year":"2005","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.bcp.2020.114043_b0300","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1474-4422(11)70047-3","article-title":"The pharmacological treatment of epilepsy in adults","volume":"10","author":"Perucca","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5698\/1535-7511-12.4s.22","article-title":"AED treatment through different ages: as our brains change, should our drug choices also?","volume":"12","author":"French","year":"2012","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.bcp.2020.114043_b0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","article-title":"The challenge of managing drug interactions in elderly people","volume":"370","author":"Mallet","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114043_b0315","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2020.114043_b0320","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1528-1167.2008.01579.x","article-title":"The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country","volume":"49","author":"Picot","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0325","first-page":"71","article-title":"Severe myoclonic epilepsy in infancy: dravet syndrome","volume":"95","author":"Dravet","year":"2005","journal-title":"Adv. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2020.114043_b0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0335","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1528-1157.1999.tb02048.x","article-title":"Stiripentol: efficacy and tolerability in children with epilepsy","volume":"40","author":"Perez","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0340","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","article-title":"From snake venom toxins to therapeutics\u2014cardiovascular examples","volume":"59","author":"Koh","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0345","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4161\/chan.2.2.6022","article-title":"Peptide toxins that selectively target insect NaV and CaV channels","volume":"2","author":"King","year":"2008","journal-title":"Channels"},{"key":"10.1016\/j.bcp.2020.114043_b0350","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1134\/S0006297909130069","article-title":"Molecular diversity of spider venom","volume":"74","author":"Vassilevski","year":"2009","journal-title":"Biochemistry (Mosc)."},{"key":"10.1016\/j.bcp.2020.114043_b0355","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","article-title":"SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain","volume":"75","author":"Liao","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114043_b0360","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.toxicon.2013.07.012","article-title":"Scorpion venom components that affect ion-channels function","volume":"76","author":"Quintero-Hernandez","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0365","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41467-018-03091-5","article-title":"The assassin bug Pristhesancus plagipennis produces two distinct venoms in separate gland lumens","volume":"9","author":"Walker","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2020.114043_b0370","doi-asserted-by":"crossref","first-page":"eaau4640","DOI":"10.1126\/sciadv.aau4640","article-title":"A comprehensive portrait of the venom of the giant red bull ant, Myrmecia gulosa, reveals a hyperdiverse hymenopteran toxin gene family","volume":"4","author":"Robinson","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2020.114043_b0375","series-title":"Venoms to Drugs: Venoms as a Source for the Development of Human Therapeutics","first-page":"163","article-title":"The molecular diversity of Conoidean venom peptides and their targets: from basic research to therapeutic applications","author":"Teichert","year":"2015"},{"key":"10.1016\/j.bcp.2020.114043_b0380","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez de la Vega RC, Corzo G, Possani LD. Scorpion venoms as a platform for drug development. In: King GF, editor. Venoms to Drugs: Venoms as a Source for the Development of Human Therapeutics. London, UK: Royal Society of Chemistry, 2015. p. 204\u2013220.","DOI":"10.1039\/9781849737876-00204"},{"key":"10.1016\/j.bcp.2020.114043_b0385","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/toxins8010030","article-title":"The biochemical toxin arsenal from ant venoms","volume":"8","author":"Touchard","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2020.114043_b0390","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/17460441.2016.1235155","article-title":"Centipede venoms as a source of drug leads","volume":"11","author":"Undheim","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bcp.2020.114043_b0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxicon.2018.11.298","article-title":"Versatile spider venom peptides and their medical and agricultural applications","volume":"158","author":"Saez","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0400","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0167-7799(00)88996-9","article-title":"Combinatorial peptide libraries in drug design: lessons from venomous cone snails","volume":"13","author":"Olivera","year":"1995","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bcp.2020.114043_b0405","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2004.07.016","article-title":"Were arachnids the first to use combinatorial peptide libraries?","volume":"26","author":"Sollod","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2020.114043_b0410","doi-asserted-by":"crossref","unstructured":"Pineda S, Chin Y, Undheim E, Senff S, Mobli M, Dauly C, et al., Structural venomics reveals evolution of a complex venom by duplication and diversification of an ancient peptide-encoding gene, Proc Natl Acad Sci USA (2020) in press.","DOI":"10.1073\/pnas.1914536117"},{"key":"10.1016\/j.bcp.2020.114043_b0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00726-010-0516-4","article-title":"Venomics: a new paradigm for natural products-based drug discovery","volume":"40","author":"Vetter","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2020.114043_b0420","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bcp.2011.10.014","article-title":"Peptide therapeutics for CNS indications","volume":"83","author":"McGonigle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0425","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.bmc.2017.09.011","article-title":"Therapeutic peptides for CNS indications: Progress and challenges","volume":"26","author":"Morimoto","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063865","article-title":"Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli","volume":"8","author":"Klint","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2020.114043_b0435","series-title":"Venoms to Drugs: Venoms as a Source for the Development of Human Therapeutics","first-page":"290","article-title":"Manufacturing of venom- derived therapeutic peptides","author":"Werbitzky","year":"2015"},{"key":"10.1016\/j.bcp.2020.114043_b0440","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cbpa.2014.09.021","article-title":"Recent extensions to native chemical ligation for the chemical synthesis of peptides and proteins","volume":"22","author":"Malins","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b0445","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4155\/fmc-2016-0175","article-title":"Modern tools for the chemical ligation and synthesis of modified peptides and proteins","volume":"8","author":"Gentilucci","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b0450","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12934-016-0617-1","article-title":"High-throughput expression of animal venom toxins in Escherichia coli to generate a large library of oxidized disulphide-reticulated peptides for drug discovery","volume":"16","author":"Turchetto","year":"2017","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.bcp.2020.114043_b0455","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2020.114043_b0460","doi-asserted-by":"crossref","first-page":"20150133","DOI":"10.1098\/rstb.2015.0133","article-title":"A molecular palaeobiological exploration of arthropod terrestrialization","volume":"371","author":"Lozano-Fernandez","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bcp.2020.114043_b0465","unstructured":"World Spider Catalog. Available online at http:\/\/wsc.nmbe.ch, version 20.5, accessed on May 6, 2020. Natural History Museum Bern, 2020."},{"key":"10.1016\/j.bcp.2020.114043_b0470","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0041-0101(01)00199-4","article-title":"Pharmacology and biochemistry of spider venoms","volume":"40","author":"Rash","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387668-3.00001-5","article-title":"Venom composition and strategies in spiders: is everything possible?","volume":"40","author":"Kuhn-Nentwig","year":"2011","journal-title":"Adv. Insect. Phys."},{"key":"10.1016\/j.bcp.2020.114043_b0480","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/pro.5560031022","article-title":"A common structural motif incorporating a cystine knot and a triple-stranded \u03b2-sheet in toxic and inhibitory polypeptides","volume":"3","author":"Pallaghy","year":"1994","journal-title":"Protein Sci."},{"key":"10.1016\/j.bcp.2020.114043_b0485","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0041-0101(98)00149-4","article-title":"The cystine knot structure of ion channel toxins and related polypeptides","volume":"36","author":"Norton","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0490","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1081\/TXR-120014409","article-title":"Structure and function of insecticidal neurotoxins from Australian funnel-web spiders","volume":"21","author":"King","year":"2002","journal-title":"J. Toxicol. Toxin Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0495","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.3390\/toxins7104366","article-title":"The cystine knot is responsible for the exceptional stability of the insecticidal spider toxin \u03c9-hexatoxin-Hv1a","volume":"7","author":"Herzig","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2020.114043_b0500","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2020.114043_b0505","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1073\/pnas.77.1.639","article-title":"Covalent labeling of protein components of the sodium channel with a photoactivable derivative of scorpion toxin","volume":"77","author":"Beneski","year":"1980","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b0510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International Union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0515","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.toxicon.2012.04.337","article-title":"Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads","volume":"60","author":"Klint","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0520","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.aaw2999","article-title":"Molecular basis for pore blockade of human Na+ channel NaV1.2 by the \u03bc-conotoxin KIIIA","volume":"363","author":"Pan","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0525","doi-asserted-by":"crossref","first-page":"eaau2596","DOI":"10.1126\/science.aau2596","article-title":"Structural basis for the modulation of voltage-gated sodium channels by animal toxins","volume":"362","author":"Shen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0530","doi-asserted-by":"crossref","unstructured":"Xu H, Li T, Rohou A, Arthur CP, Tzakoniati F, Wong E, et al., Structural basis of Nav1.7 inhibition by a gating-modifier spider toxin, Cell 176 (2019) 702-715 e714.","DOI":"10.1016\/j.cell.2018.12.018"},{"key":"10.1016\/j.bcp.2020.114043_b0535","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aaw2493","article-title":"Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins","volume":"363","author":"Shen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0540","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/B978-0-444-52891-9.00065-8","article-title":"Dravet syndrome severe myoclonic epilepsy in infancy","volume":"111","author":"Dravet","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0545","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation","volume":"27","author":"Ogiwara","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0550","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/epi.12213","article-title":"Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome","volume":"54","author":"Liautard","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0555","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature17976","article-title":"Selective spider toxins reveal a role for the NaV1.1 channel in mechanical pain","volume":"534","author":"Osteen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0560","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(02)09968-3","article-title":"Sodium-channel defects in benign familial neonatal-infantile seizures","volume":"360","author":"Heron","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114043_b0565","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.20029","article-title":"Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy","volume":"55","author":"Berkovic","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0570","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/brain\/awx054","article-title":"Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders","volume":"140","author":"Wolff","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b0575","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tins.2018.03.011","article-title":"Progress in understanding and treating SCN2A-mediated disorders","volume":"41","author":"Sanders","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0580","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.eplepsyres.2014.08.020","article-title":"et al., Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy","volume":"108","author":"de Kovel","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bcp.2020.114043_b0585","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.24580","article-title":"Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation","volume":"79","author":"Gardella","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0590","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nn.2359","article-title":"Distinct contributions of NaV1.6 and NaV1.2 in action potential initiation and backpropagation","volume":"12","author":"Hu","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0595","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fncel.2014.00297","article-title":"Molecular identity of axonal sodium channels in human cortical pyramidal cells","volume":"8","author":"Tian","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0600","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/mol.105.015941","article-title":"Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes","volume":"69","author":"Bosmans","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0605","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0610","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1074\/jbc.RA118.002553","article-title":"Gating modifier toxins isolated from spider venom: modulation of voltage-gated sodium channels and the role of lipid membranes","volume":"293","author":"Agwa","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b0615","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41598-017-17344-8","article-title":"Differential roles of NaV1.2 and NaV1.6 in regulating neuronal excitability at febrile temperature and distinct contributions to febrile seizures","volume":"8","author":"Ye","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114043_b0620","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1074\/jbc.M605403200","article-title":"Solution structure and alanine scan of a spider toxin that affects the activation of mammalian voltage-gated sodium channels","volume":"282","author":"Corzo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b0625","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0959-440X(00)00114-7","article-title":"Potassium channel structure: domain by domain","volume":"10","author":"Biggin","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b0630","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.280.5360.69","article-title":"The structure of the potassium channel: molecular basis of K+ conduction and selectivity","volume":"280","author":"Doyle","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0635","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1126\/science.2476850","article-title":"Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor","volume":"245","author":"MacKinnon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0640","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1126\/science.2000495","article-title":"Exchange of conduction pathways between two related K+ channels","volume":"251","author":"Hartmann","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0645","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/349700a0","article-title":"Alteration of ionic selectivity of a K+ channel by mutation of the H5 region","volume":"349","author":"Yool","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0650","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0896-6273(94)90452-9","article-title":"The charybdotoxin receptor of a Shaker K+ channel: peptide and channel residues mediating molecular recognition","volume":"12","author":"Goldstein","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2020.114043_b0655","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/350232a0","article-title":"Determination of the subunit stoichiometry of a voltage-activated potassium channel","volume":"350","author":"MacKinnon","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0660","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1126\/science.7694359","article-title":"Functional stoichiometry of shaker potassium channel inactivation","volume":"262","author":"MacKinnon","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0665","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1126\/science.7716527","article-title":"Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor","volume":"268","author":"Hildago","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b0670","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0896-6273(93)90076-4","article-title":"Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release","volume":"11","author":"Robitaille","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2020.114043_b0675","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng1094-136","article-title":"Episodic ataxia\/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1","volume":"8","author":"Browne","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0680","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.3144","article-title":"A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy","volume":"47","author":"Muona","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0685","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0198-25","article-title":"A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns","volume":"18","author":"Singh","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0690","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/humu.23149","article-title":"Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes","volume":"38","author":"Parrini","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2020.114043_b0695","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ng.3282","article-title":"Mutations in KCNH1 and ATP6V1B2 cause zimmermann-laband syndrome","volume":"47","author":"Kortum","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0700","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCD.0000000000000072","article-title":"Two cases of temple-baraitser syndrome: natural history and further delineation of the clinical and radiological phenotypes","volume":"24","author":"Shen","year":"2015","journal-title":"Clin. Dysmorphol."},{"key":"10.1016\/j.bcp.2020.114043_b0705","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K+ channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0710","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Caterall","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bcp.2020.114043_b0715","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0720","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.neuro.31.060407.125631","article-title":"Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system","volume":"31","author":"Flavell","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0725","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/er.2005-0888","article-title":"The role of voltage-gated calcium channels in pancreatic \u03b2-cell physiology and pathophysiology","volume":"27","author":"Yang","year":"2006","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0730","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/toxins5020286","article-title":"Venom peptides as a rich source of CaV2.2 channel blockers","volume":"5","author":"Sousa","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2020.114043_b0735","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4161\/chan.4.6.12871","article-title":"G protein inhibition of CaV2 calcium channels","volume":"4","author":"Currie","year":"2010","journal-title":"Channels"},{"key":"10.1016\/j.bcp.2020.114043_b0740","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/s41598-019-39703-3","article-title":"CaV3.2 T-type calcium channels shape electrical firing in mouse lamina II neurons","volume":"9","author":"Candelas","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114043_b0745","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2020.114043_b0750","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology","volume":"594","author":"Dolphin","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2020.114043_b0755","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-019-1801-3","article-title":"Cryo-EM stucture of apo and antagonist-bound human CaV3.1","volume":"576","author":"Zhao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0760","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev.bi.63.070194.004135","article-title":"Calcium channel diversity and neurotransmitter release: the \u03c9-conotoxins and \u03c9-agatoxins","volume":"63","author":"Olivera","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2020.114043_b0765","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/bi981255g","article-title":"Selective peptide anatagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas","volume":"37","author":"Newcomb","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2020.114043_b0770","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/372272a0","article-title":"Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin","volume":"372","author":"Ellinor","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0775","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/ejhg.2015.21","article-title":"CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms","volume":"23","author":"Damaj","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0780","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1152\/jn.1999.81.5.2066","article-title":"Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4lh) and tottering (Cacna1atg) mouse thalami","volume":"81","author":"Caddick","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2020.114043_b0785","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-4522(99)00446-7","article-title":"Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the \u03b11A subunit of P\/Q type calcium channels","volume":"95","author":"Ayata","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2020.114043_b0790","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/302909","article-title":"Coding and noncoding variation of the human calcium-channel \u03b24-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia","volume":"66","author":"Escayg","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0795","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.21169","article-title":"Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants","volume":"62","author":"Heron","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0800","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0805","doi-asserted-by":"crossref","first-page":"13341","DOI":"10.1523\/JNEUROSCI.1421-08.2008","article-title":"Transcriptional upregulation of CaV3.2 mediates epileptogenesis in the pilocarpine model of epilepsy","volume":"28","author":"Becker","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0810","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/md15100313","article-title":"Conotoxins as tools to understand the physiological function of voltage-gated calcium (CaV) channels","volume":"15","author":"Ramirez","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2020.114043_b0815","series-title":"Venoms to Drugs: Venoms as a Source for the Development of Human Therapeutics","first-page":"221","article-title":"Therapeutic applications of spider-venom peptides","author":"Smith","year":"2015"},{"key":"10.1016\/j.bcp.2020.114043_b0820","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.105.087023","article-title":"Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6","volume":"314","author":"Vieira","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2020.114043_b0825","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bph.13652","article-title":"The peptide Ph\u03b11\u03b2, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice","volume":"174","author":"Tonello","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0830","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1007\/s12035-018-1049-1","article-title":"Beneficial effects of the calcium channel blocker CTK 01512\u20132 in a mouse model of multiple sclerosis","volume":"55","author":"Silva","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2020.114043_b0835","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.neuroscience.2014.07.065","article-title":"The spinal inhibition of N-type voltage-gated calcium channels selectively prevents scratching behavior in mice","volume":"277","author":"Maciel","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2020.114043_b0840","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxicon.2017.02.001","article-title":"Pre-clinical evaluation of voltage-gated calcium channel blockers derived from the spider P. nigriventer in glioma progression","volume":"129","author":"Nicoletti","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114043_b0845","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04708","article-title":"Recent advances in Cys-loop receptor structure and function","volume":"440","author":"Sine","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0850","doi-asserted-by":"crossref","first-page":"40232","DOI":"10.1074\/jbc.R112.406280","article-title":"Glutamate-gated chloride channels","volume":"287","author":"Wolstenholme","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b0855","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbiomolbio.2003.09.002","article-title":"Ligand-gated ion channels: mechanisms underlying ion selectivity","volume":"86","author":"Keramidas","year":"2004","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2017.03.003","article-title":"GABAA receptors and the diversity in their structure and pharmacology","volume":"79","author":"Chua","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b0865","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0870","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/35077011","article-title":"Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors","volume":"411","author":"Brejc","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0875","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.sbi.2019.03.023","article-title":"A structural perspective on GABAA receptor pharmacology","volume":"54","author":"Scott","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b0880","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0885","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2020.114043_b0890","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature08624","article-title":"X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor","volume":"462","author":"Sobolevsky","year":"2009","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2020.114043_b0895","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.33549\/physiolres.932678","article-title":"Structure, function, and pharmacology of NMDA receptor channels","volume":"63","author":"Vyklicky","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bcp.2020.114043_b0900","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nature19367","article-title":"X-ray structures define human P2X3 receptor gating cycle and antagonist action","volume":"538","author":"Mansoor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b0905","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2016.0449","article-title":"Molecular pathogenic basis for GABRG2 mutations associated with a spectrum of epilepsy syndromes, from generalized absence epilepsy to Dravet syndrome","volume":"73","author":"Kang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b0910","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng0501-46","article-title":"First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene","volume":"28","author":"Baulac","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0915","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","article-title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy","volume":"31","author":"Cossette","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0920","doi-asserted-by":"crossref","unstructured":"Epi4K Consortium, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, et al., De novo mutations in epileptic encephalopathies, Nature 501 (2013) 217\u2013221.","DOI":"10.1038\/nature12439"},{"key":"10.1016\/j.bcp.2020.114043_b0925","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/81566","article-title":"The nicotinic receptor \u03b22 subunit is mutant in nocturnal frontal lobe epilepsy","volume":"26","author":"De Fusco","year":"2000","journal-title":"Nat. Genet."},{"issue":"Suppl 5","key":"10.1016\/j.bcp.2020.114043_b0930","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1528-1157.43.s.5.16.x","article-title":"How mutations in the nAChRs can cause ADNFLE epilepsy","volume":"43","author":"Bertrand","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0935","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1523\/JNEUROSCI.1509-11.2011","article-title":"Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors","volume":"31","author":"Harpsoe","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b0940","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.phrs.2018.11.031","article-title":"Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry","volume":"139","author":"Indurthi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2020.114043_b0945","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/s41467-019-10910-w","article-title":"AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders","volume":"10","author":"Salpietro","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2020.114043_b0950","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cophys.2017.12.013","article-title":"De novo mutations and rare variants occurring in NMDA receptors","volume":"2","author":"XiangWei","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.bcp.2020.114043_b0955","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1038\/ncomms4251","article-title":"Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy","volume":"5","author":"Yuan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2020.114043_b0960","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ng.677","article-title":"Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes","volume":"42","author":"Endele","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0965","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajhg.2016.07.013","article-title":"GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers","volume":"99","author":"Li","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b0970","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.2174\/1381612823666170809100230","article-title":"Modulation of GABAA receptors in the treatment of epilepsy","volume":"23","author":"Palma","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2020.114043_b0975","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106459","article-title":"Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures","volume":"99","author":"Klein","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bcp.2020.114043_b0985","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1073\/pnas.1415488112","article-title":"MmTX1 and MmTX2 from coral snake venom potently modulate GABAA receptor activity","volume":"112","author":"Rosso","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b0990","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/brain\/awy171","article-title":"De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy","volume":"141","author":"Butler","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b0995","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0987-7053(02)00294-0","article-title":"Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE","volume":"32","author":"Itier","year":"2002","journal-title":"Neurophysiol. Clin."},{"key":"10.1016\/j.bcp.2020.114043_b1000","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/jpet.110.171108","article-title":"The anticonvulsive drug lamotrigine blocks neuronal \u03b14\u03b22 nicotinic acetylcholine receptors","volume":"335","author":"Zheng","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2020.114043_b1005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yebeh.2019.05.031","article-title":"The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy","volume":"97","author":"Chopra","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bcp.2020.114043_b1010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcp.2017.12.008","article-title":"The wonderland of neuronal nicotinic acetylcholine receptors","volume":"151","author":"Bertrand","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114043_b1015","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/ijms13022219","article-title":"\u03b17 nicotinic acetylcholine receptor is a target in pharmacology and toxicology","volume":"13","author":"Pohanka","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2020.114043_b1020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.06.011","article-title":"Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms","volume":"127","author":"Dutertre","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114043_b1025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.biochem.68.1.59","article-title":"Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes","volume":"68","author":"McIntosh","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2020.114043_b1030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/md16060208","article-title":"Neuronal nicotinic acetylcholine receptor modulators from cone snails","volume":"16","author":"Abraham","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2020.114043_b1035","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/1873-3468.13530","article-title":"Scorpion toxins interact with nicotinic acetylcholine receptors","volume":"593","author":"Kasheverov","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2020.114043_b1040","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1042\/BCJ20190255","article-title":"Toxins for decoding interface selectivity in nicotinic acetylcholine receptors","volume":"476","author":"Kini","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2020.114043_b1045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2017.04.008","article-title":"Lethal effects of an insecticidal spider venom peptide involve positive allosteric modulation of insect nicotinic acetylcholine receptors","volume":"127","author":"Windley","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114043_b1050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/chan.2.2.6276","article-title":"Subtype-selective conopeptides targeted to nicotinic receptors: concerted discovery and biomedical applications","volume":"2","author":"Olivera","year":"2008","journal-title":"Channels"},{"key":"10.1016\/j.bcp.2020.114043_b1055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5698\/1535-7511-11.2.56","article-title":"Revisiting AMPA receptors as an antiepileptic drug target","volume":"11","author":"Rogawski","year":"2011","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.bcp.2020.114043_b1060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(89)90804-5","article-title":"Involvement of non-NMDA receptors in picrotoxin-induced epileptiform activity in the hippocampus","volume":"107","author":"Lee","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2020.114043_b1065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1152\/jn.1991.65.4.771","article-title":"Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices","volume":"65","author":"Perreault","year":"1991","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2020.114043_b1070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00228949","article-title":"The involvement of excitatory amino acids in neocortical epileptogenesis: NMDA and non-NMDA receptors","volume":"86","author":"Hwa","year":"1991","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bcp.2020.114043_b1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106876","article-title":"Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: post hoc analysis of six randomized studies","volume":"104","author":"Pina-Garza","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bcp.2020.114043_b1080","article-title":"Spider toxins targeting ligand-gated ion channels","author":"Filchakova","year":"2019","journal-title":"Toxin Rev."},{"key":"10.1016\/j.bcp.2020.114043_b1085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/01.wnr.0000185012.98821.2b","article-title":"The antiepileptic activity of JSTX-3 is mediated by N-methyl-D-aspartate receptors in human hippocampal neurons","volume":"16","author":"Salamoni","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.bcp.2020.114043_b1090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1023\/A:1021836403433","article-title":"Phoneutria nigriventer venom: a cocktail of toxins that affect ion channels","volume":"22","author":"Gomez","year":"2002","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2020.114043_b1095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2020.114043_b1100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-019-0013-8","article-title":"Antibodies and venom peptides: new modalities for ion channels","volume":"18","author":"Wulff","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2020.114043_b1105","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4155\/fmc.14.103","article-title":"Spider venomics: implications for drug discovery","volume":"6","author":"Pineda","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b1110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2020.114043_b1115","article-title":"Deadly proteomes: the central role of proteomics in dissecting the chemical arsenal of animal venoms","author":"Walker","year":"2020","journal-title":"Proteomics"},{"key":"10.1016\/j.bcp.2020.114043_b1120","series-title":"Venoms to Drugs: Venoms as a Source for the Development of Human Therapeutics","first-page":"97","article-title":"Venoms-based drug discovery: bioassays, electrophysiology, high-throughput screens and target identification","author":"Vetter","year":"2015"},{"key":"10.1016\/j.bcp.2020.114043_b1125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2017.03.038","article-title":"Pharmacological screening technologies for venom peptide discovery","volume":"127","author":"Prashanth","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114043_b1130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nsb0797-559","article-title":"The structure of a novel insecticidal neurotoxin, \u03c9-atracotoxin-HV1, from the venom of an Australian funnel web spider","volume":"4","author":"Fletcher","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b1135","doi-asserted-by":"crossref","first-page":"47564","DOI":"10.1074\/jbc.M204063200","article-title":"Function and solution structure of huwentoxin-IV, a potent neuronal tetrodotoxin (TTX)-sensitive sodium channel antagonist from Chinese bird spider Selenocosmia huwena","volume":"277","author":"Peng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114043_b1140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/75921","article-title":"Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge","volume":"7","author":"Wang","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b1145","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1021\/bi011932y","article-title":"Solution structures of the cis- and trans-Pro30 isomers of a novel 38-residue toxin from the venom of Hadronyche infensa sp. that contains a cystine-knot motif within its four disulfide bonds","volume":"41","author":"Rosengren","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2020.114043_b1150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1006\/jmbi.2000.3609","article-title":"Solution structure of hanatoxin1, a gating modifier of voltage-dependent K+ channels: common surface features of gating modifier toxins","volume":"297","author":"Takahashi","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2020.114043_b1155","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0969-2126(97)00301-8","article-title":"The structure of versutoxin (\u03b4-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel","volume":"5","author":"Fletcher","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2020.114043_b1160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature10238","article-title":"The crystal structure of a voltage-gated sodium channel","volume":"475","author":"Payandeh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b1165","doi-asserted-by":"crossref","first-page":"eaal4326","DOI":"10.1126\/science.aal4326","article-title":"Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution","volume":"355","author":"Shen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114043_b1170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-018-0833-4","article-title":"Cryo-EM structure of the human \u03b11\u03b23\u03b32 GABAA receptor in a lipid bilayer","volume":"565","author":"Laverty","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b1175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature23479","article-title":"Channel opening and gating mechanism in AMPA-subtype glutamate receptors","volume":"549","author":"Twomey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114043_b1180","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","article-title":"Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization","volume":"179","author":"McCarthy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2020.114043_b1185","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1190","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/319524","article-title":"A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus\u2014and prevalence of variants in patients with epilepsy","volume":"68","author":"Escayg","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1195","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/brain\/awm002","article-title":"The spectrum of SCN1A-related infantile epileptic encephalopathies","volume":"130","author":"Harkin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b1200","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1523\/JNEUROSCI.2475-09.2009","article-title":"A functional null mutation of SCN1B in a patient with Dravet syndrome","volume":"29","author":"Patino","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b1205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/brain\/awl272","article-title":"Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations","volume":"130","author":"Scheffer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b1210","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/1252","article-title":"Febrile seizures and generalized epilepsy associated with a mutation in the Na+ channel \u03b21 subunit gene SCN1B","volume":"19","author":"Wallace","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1215","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.braindev.2009.08.009","article-title":"Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome","volume":"31","author":"Shi","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.bcp.2020.114043_b1220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jmedgenet-2019-106373","article-title":"Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia","volume":"57","author":"Verdura","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng.3239","article-title":"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy","volume":"47","author":"Syrbe","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1230","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0000000000003309","article-title":"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy","volume":"87","author":"Corbett","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114043_b1235","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejpn.2016.03.011","article-title":"Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: expansion of the genotypic and phenotypic spectrum","volume":"20","author":"Hundallah","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.24263","article-title":"De novo KCNB1 mutations in epileptic encephalopathy","volume":"76","author":"Torkamani","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1245","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1038\/srep15199","article-title":"De novo KCNB1 mutations in infantile epilepsy inhibit repetitive neuronal firing","volume":"5","author":"Saitsu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114043_b1250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nbd.2006.07.001","article-title":"A Kv4.2 truncation mutation in a patient with temporal lobe epilepsy","volume":"24","author":"Singh","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2020.114043_b1255","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2015.04.017","article-title":"A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels","volume":"80","author":"Abidi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2020.114043_b1260","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1073\/pnas.1216867110","article-title":"Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of KV7.2 potassium channel subunits","volume":"110","author":"Miceli","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b1265","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1523\/JNEUROSCI.4423-14.2015","article-title":"Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits","volume":"35","author":"Miceli","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b1270","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.24080","article-title":"Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy","volume":"75","author":"Orhan","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.22644","article-title":"KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy","volume":"71","author":"Weckhuysen","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1280","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1531-8249(200006)47:6<822::AID-ANA19>3.0.CO;2-X","article-title":"A novel mutation of KCNQ3 (c.925T\u2192C) in a Japanese family with benign familial neonatal convulsions","volume":"47","author":"Hirose","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000447461","article-title":"Novel KCNQ3 nutation in a large family with benign familial neonatal epilepsy: a rare cause of neonatal seizures","volume":"7","author":"Maljevic","year":"2016","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.bcp.2020.114043_b1290","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/brain\/awh301","article-title":"Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia","volume":"127","author":"Imbrici","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b1295","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(01)05971-2","article-title":"Human epilepsy associated with dysfunction of the brain P\/Q-type calcium channel","volume":"358","author":"Jouvenceau","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114043_b1300","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1523\/JNEUROSCI.22-09-03645.2002","article-title":"Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus","volume":"22","author":"Su","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114043_b1305","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.0000000000003087","article-title":"Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies","volume":"87","author":"Johannesen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114043_b1310","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ana.20874","article-title":"A mutation in the GABAA receptor \u03b11-subunit is associated with absence epilepsy","volume":"59","author":"Maljevic","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1315","first-page":"2879","article-title":"Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features","volume":"140","author":"Niturad","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114043_b1320","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1113\/jphysiol.2011.218883","article-title":"The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters \u03b16\u03b22\u03b32 and \u03b16\u03b22\u03b3 GABAA receptor channel gating and expression","volume":"589","author":"Hernandez","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2020.114043_b1325","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ana.24631","article-title":"Epileptic encephalopathy de novo GABRB mutations impair \u03b3-aminobutyric acid type A receptor function","volume":"79","author":"Janve","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1330","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.24699","article-title":"A second patient with a De Novo GABRB1 mutation and epileptic encephalopathy","volume":"80","author":"Lien","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114043_b1335","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/ajmg.a.36714","article-title":"A novel variant in GABRB2 associated with intellectual disability and epilepsy","volume":"164A","author":"Srivastava","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bcp.2020.114043_b1340","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jmedgenet-2016-104083","article-title":"A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy","volume":"54","author":"Ishii","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1345","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ajhg.2008.04.020","article-title":"Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy","volume":"82","author":"Tanaka","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1350","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/338710","article-title":"Truncation of the GABAA receptor \u03b32 subunit in a family with generalised epilepsy with febrile seizures plus","volume":"70","author":"Harkin","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1355","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/506459","article-title":"Increased sensitivity of the neuronal nicotinic receptor \u03b12 subunit causes familial epilepsy with nocturnal wandering and ictal fear","volume":"79","author":"Aridon","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114043_b1360","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/epi.12967","article-title":"Mutation of CHRNA2 in a family with benign familial infantile seizures: potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy","volume":"56","author":"Trivisano","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b1365","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1528-1167.2007.01328.x","article-title":"Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene","volume":"49","author":"Diaz-Otero","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114043_b1370","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1212\/WNL.0000000000002740","article-title":"Delineating the GRIN1 phenotypic spectrum: a distinct genetic NMDA receptor encephalopathy","volume":"86","author":"Lemke","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114043_b1375","doi-asserted-by":"crossref","first-page":"18163","DOI":"10.1073\/pnas.0708699104","article-title":"Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans","volume":"104","author":"Wu","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114043_b1380","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ajhg.2017.11.004","article-title":"De novo variants in GRIA4 lead to intellectual disability with or without seizures and gait abnormalities","volume":"101","author":"Martin","year":"2017","journal-title":"Am. J. Hum. Genet."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522030277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522030277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:16:50Z","timestamp":1757769410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522030277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":276,"alternative-id":["S000629522030277X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114043","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venom-derived modulators of epilepsy-related ion channels","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114043"}}